Omeros Corporation (OMER)

[umiak]

This is from a knowledgeable long.
I have not fact checked it yet. Any post from anyone should be checked out personally.

“Feb. 11, 2019 $ABBVV did a PRECLINICAL STAGE deal with Teneobio to for TNB-383B, a BCMA-targeting immunotherapeutic for the potential treatment of multiple myeloma.
How much up front?
$90MM for the one indication and it does NOT give them ownership of the drug or even right to develop it, unless they pay much more to be determined at a later date.
news.abbvie.com/news/abbvie...

November 21, 2019 $ABBV buys OPTION TO LICENCE PRECLINICAL HPN217 from Har­poon for BC­MA in mul­ti­ple myelo­ma.
How much up-front for this preclinical drug candidate for this one indication?
$50MM& an­oth­er $50 mil­lion IF THEY DOSE ONE PATIENT.
And it is only for the OPTION TO LICENSE.
endpts.com/abbvie-scoops-up... “